Figure 6.
Modification of the AJCC 8th TNM staging system for PADC. (A,B) After combining all the “H” subgroups into one stage, the survival curve of the new H stage was similar to that of subgroup IIIL, and no significant difference in CSS was found between IBL and IIAL in training set (P=0.980); (C) Survival difference between H stage and subgroup IIBL was statistically significant (P=0.035); (D) No significant difference was found between IBL and IIAL (P=0.760). AJCC, American Joint Committee on Cancer; PDAC, pancreatic ductal adenocarcinoma.